Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.
Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

Tanaka Rie

275 indexed publications match this author name.

ORCID
Not found in stored metadata
OpenAlex
Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Publication history

Prevalence and Reasons for Microdosing Cannabis, Psilocybin, LSD, and MDMA Among U.S. AdultsAmerican Journal of Preventive Medicine · 2026-10-01Genome-based optimization of psilocybin and N,N-dimethyltryptamine biosynthetic pathways in E. coli using CRISPR-associated transposasesMetabolic Engineering · 2026-09-01Safety for Home Administration of Microdose Psilocybin UseClinicalTrials.gov · 2026-08-14Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12Circulating MicroRNAs and Their Associations with Neurotrophic, Inflammatory and Glutamate Markers in Healthy VolunteersbioRxiv · 2026-08-10Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in healthy young adultsbioRxiv · 2026-08-10A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10A suite of engineered mice for interrogating psychedelic drug actions.Nature neuroscience · 2026-08-06Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29Beyond Monoamines: Ketamine, Esketamine, and Classic Psychedelics in the Treatment of DepressionZenodo (CERN European Organization for Nuclear Research) · 2026-07-17The Effects of Psilocybin on Social ConnectednessClinicalTrials.gov · 2026-07-09Psilocybin therapy for adult females with anorexia nervosa: pilot studyThe British Journal of Psychiatry · 2026-07-08α2-Adrenergic receptor modulates 5-HT2A-mediated behavioral effects of MDMA and psilocybin in miceMolecular Psychiatry · 2026-07-07Consciousness and Psilocybin Effects on Well-Being: The CoPEWell StudyClinicalTrials.gov · 2026-07-02Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive SymptomsClinicalTrials.gov · 2026-07-01An Open-Label Study of Single-Dose Psilocybin for Borderline Personality Disorder With Co-Occurring Major Depressive DisorderClinical Neuropharmacology · 2026-07-01Blinding Integrity in Psychedelic Randomized Clinical Trials: A Systematic Review.JAMA psychiatry · 2026-07-01Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-07-01The purpose of the psychosocial protocol in the psychedelic-assisted therapy: A scoping review.Journal of psychopharmacology (Oxford, England) · 2026-07-01Acute dose-dependent effects of 4-bromo-2,5-dimethoxyphenethylamine (2C-B) compared with 3,4-methylenedioxymethamphetamine (MDMA) and psilocybin in a double-blind, placebo-controlled study in healthy participantsNeuropsychopharmacology · 2026-07-01PSILOCYBIN IN THE TREATMENT OF DEPRESSIVE DISORDERS: CLINICAL EVIDENCE AND ITS POTENTIAL TO ADDRESS THE GLOBAL MENTAL HEALTH CRISIS - A REVIEWInternational Journal of Innovative Technologies in Social Science · 2026-06-24Psilocybin-Assisted Therapy for Prolonged GriefClinicalTrials.gov · 2026-06-23Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-AnalysisPsychiatry International · 2026-06-15Alcohol consumption and substance use among French medical students: A nationwide cross-sectional study: Consommation d'alcool et de substances chez les étudiants en médecine de France: une étude transversale nationale.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-06-09Multivariate Neural and Physiological Correlates of Psychedelic Sub-states: a Within-subjects, Healthy Volunteer Study With Experience-samplingClinicalTrials.gov · 2026-06-05The Role of the Subjective Experience in Supporting Positive Effects Following Psilocybin: a Randomized, Controlled Clinical Trial Using Risperidone in Healthy AdultsClinicalTrials.gov · 2026-06-02Psilocybin shows rapid relief for depression symptomsMental Health Weekly · 2026-06-01Impact of formulation variables on the quality attributes of psilocybin-loaded oral thin films for early-phase developmentJournal of Drug Delivery Science and Technology · 2026-06-01U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.Rand health quarterly · 2026-06-01Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.Molecular psychiatry · 2026-05-29Blinding integrity in psychedelic research: Evidence from a comparative randomized controlled trial of psilocybin, MDMA, and methylphenidate in healthy volunteers.Open Access CRIS of the University of Bern · 2026-05-28Epigenome-wide association study of psilocybin-induced methylome changes in alcohol use disorderTranslational Psychiatry · 2026-05-26Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of CareCurrent Psychiatry Reports · 2026-05-14Psilocybin in the Treatment of Cocaine Use DisorderJAMA Network Open · 2026-05-07The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratusFrontiers in Behavioral Neuroscience · 2026-05-07Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06Acute Effects of 4-Bromo-2,5-Dimethoxyphenethylamine (2C-B) Compared With Psilocybin and MDMA in Healthy ParticipantsBiological Psychiatry · 2026-05-01High dose of psilocybin induces acute behavioral changes without inducing conditioned place preference in Sprague-Dawley rats.Journal of psychopharmacology (Oxford, England) · 2026-05-01Integrating the Mystical Experience Questionnaire Into a Broader Psychometric Framework: English Validation of the Psychedelic Experience Scale and Comparison of Psilocybin and LSD Sessions Across Two Controlled SettingsRepository for Publications and Research Data (ETH Zurich) · 2026-04-30Evaluating the evidence for repressed memory recovery in psychedelic contextsPsychopharmacology · 2026-04-28“Large-Scale and Local Functional Connectivity Changes Following Psilocybin Administration in Methamphetamine Use DisorderAmerican Journal of Neuroradiology · 2026-04-24Psilocybin Trends in States That Decriminalized UseJAMA · 2026-04-14Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use.Community mental health journal · 2026-04-01Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations.Expert opinion on pharmacotherapy · 2026-04-01Mystical dynamics: renewal, luminous light, and ego disintegration as key features associated with mystical oneness-a psychometric analysis using the PES100 in controlled psychedelic studiesReligion Brain & Behavior · 2026-03-31Psilocybin retail stores in Canada: Changes in availability, commercialization, and geographic distributionCanadian Journal of Public Health · 2026-03-19Synthesis and Characterization of Psilocybin Metabolites and Deuterated AnalogsACS Chemical Neuroscience · 2026-03-18Digital Intervention for Psychedelic Preparation (DIPP): protocol for a randomised controlled feasibility trial comparing meditation- and music-based programmes in healthy volunteers.BMJ open · 2026-03-12Psilocybin microdosing in the United States: Insights from a nationally representative surveyAddiction · 2026-03-08Public attitudes diverge sharply on legal use of psychedelicsMental Health Weekly · 2026-03-02The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.ClinicalTrials.gov · 2026-02-25Delayed psilocybin treatment after repeated mild traumatic brain injury recovers chronic behavioural deficits, reduces microglial density, and enhances hippocampal neurogenesis in ratsResearch Square · 2026-02-23Network pharmacology and molecular simulation reveal the entourage effect mechanisms of psilocybin-producing mushrooms on the brain.Scientific reports · 2026-02-14Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-02-12Mystical but Not Challenging Experiences Predict Symptom Improvement After Psilocybin for Treatment-Resistant OCDPsyArXiv · 2026-02-11Psilocybin wirkt bei therapieresistenter DepressionDNP - Die Neurologie & Psychiatrie · 2026-02-01Ketamine, Psychedelics, and Psychotherapy: Reframing, Redefining, Renaming Treatment Models.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2026-02-01RAND: Microdosing surges as millions turned to psychedelics in 2025Mental Health Weekly · 2026-01-23Temporal effects of a single oral dose of psilocybin on plasma circulating miRNAs in humansNeuroscience Applied · 2026-01-01Down the Rabbit Hole: A Large-Scale Survey of Psychedelic Users' Patterns of Use and Perceived Effects.Journal of psychoactive drugs · 2026-01-01Marketing by online tobacco retailers: An observational cross-sectional study.Tobacco induced diseases · 2026-01-01Effects of Serotonergic Psychedelics on Synaptic Function and NeuroplasticityOPUS FAU - Online publication system of Friedrich-Alexander-Universität Erlangen-Nürnberg · 2025-12-31A qualitative analysis of participant expectations and experiences of psilocybin-assisted psychotherapy for methamphetamine use disorder.Addiction (Abingdon, England) · 2025-12-22Effects of LSD and Psilocybin on Heart Rate in Patients Receiving Psychedelic Treatment for Depressive and Anxiety Disorders: A Retrospective Observational StudyPsychology International · 2025-12-19Which Psychotherapy Model Should be Used in Psilocybin Treatment for Depression?Trends in psychiatry and psychotherapy · 2025-12-17Limited prognostic value of early maladaptive schemas for acute psychedelic experience and symptom improvementResearch Square · 2025-12-01Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in SwitzerlandmedRxiv · 2025-12-01[Psilocybin in the setting of treatment-resistant unipolar depression: A case report].L'Encephale · 2025-12-01Sex-specific role of the 5-HT receptor in psilocybin-induced extinction of opioid reward.Nature communications · 2025-11-20Negative affective bias in depression following treatment with psilocybin or escitalopram - a secondary analysis from a randomized trial.Translational psychiatry · 2025-11-13Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders.Journal of psychoactive drugs · 2025-11-10Hormonal Influences on Psilocybin Responsivity Across the Female Lifespan: Toward Personalized Psychedelic-Assisted TherapyPsychoactives · 2025-11-02CNSC-36. PSILOCYBIN INDUCES SUSTAINED GLIOMA GROWTH THROUGH SEROTONERGIC AND TRKB PATHWAYSNeuro-Oncology · 2025-11-01The emotional architecture of the psychedelic brain.Trends in cognitive sciences · 2025-11-01Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applicationsCaderno Pedagógico · 2025-10-31Home-based psilocybin-assisted therapy for a patient with advanced cancer: A case report.Palliative & supportive care · 2025-10-23Psychedelic compounds directly excite 5-HT2A layer V medial prefrontal cortex neurons through 5-HT2A Gq activationUNC Libraries · 2025-10-16Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)ClinicalTrials.gov · 2025-10-07Psilocybin-assisted psychotherapy in adults with depression - A literature review.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02Differential effects of psilocybin and lisuride on serotonin and dopamine neuronal activity and behavior.Progress in neuro-psychopharmacology & biological psychiatry · 2025-10-02[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?].La Revue du praticien · 2025-10-01Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study.Addiction (Abingdon, England) · 2025-09-20Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia CarePsychoactives · 2025-09-02Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case ReportPsychoactives · 2025-09-01Severe Rhabdomyolysis With Stage 3 Acute Kidney Injury After Ayahuasca Use Managed Without Renal Replacement Therapy: A Case Report.Cureus · 2025-09-01694. INVESTIGATING THE POTENTIAL OF PSILOCYBIN FOR COMPULSIVE EATING IN A RAT MODEL OF BINGE EATINGThe international journal of neuropsychopharmacology · 2025-08-01Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.Asian journal of psychiatry · 2025-08-01Electrophysiological effects of psilocybin co-administered with midazolambioRxiv · 2025-07-29Epigenome-wide Association Study of Psilocybin-Induced Methylome Changes in Alcohol Use DisorderbioRxiv · 2025-07-18Exploring Jordanian Physicians' and Medical Students' Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East.Journal of psychoactive drugs · 2025-07-06Visual Surround Suppression and Perceptual Expectation Under PsilocybinClinicalTrials.gov · 2025-06-27Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use DisorderPsyArXiv · 2025-06-10Acute Effects and Pharmacokinetics of LSD after Paroxetine or Placebo Pre-Administration in a Randomized, Double-Blind, Cross-Over Phase I Trial.Clinical pharmacology and therapeutics · 2025-06-01Consciousness and Psilocybin Effects on Well-Being (The CoPE Study): Pilot PhaseClinicalTrials.gov · 2025-05-16Psilocybin for disorders of consciousness: A case-report study.Clinical neurophysiology: official journal of the International Federation of Clinical Neurophysiology · 2025-05-01Neuroplasticity and psychedelics: A comprehensive examination of classic and non-classic compounds in pre and clinical models.Neuroscience and biobehavioral reviews · 2025-05-01Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A surveyJournal of Psychedelic Studies · 2025-04-22Regulatory Challenges of Integrating Psychedelics into Mental Health SectorPsychoactives · 2025-04-22The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14Functional and structural characterization of the human indolethylamine N-methyltransferase through fluorometric, thermal and computational docking analyses.Biology direct · 2025-04-1013. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging StudyBiological Psychiatry · 2025-04-09595. Psilocybin-Assisted Therapy for Relapse Prevention in Alcohol Use Disorder: A RCTBiological Psychiatry · 2025-04-09Sporadic use of classic psychedelics and neuropsychological performance: A cross-sectional analysis.Progress in neuro-psychopharmacology & biological psychiatry · 2025-04-02Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trialUniversität Zürich, ZORA · 2025-04-01Psilocybin Dispensaries and Online Health Claims in Canada.JAMA network open · 2025-04-01The renaissance of psychedelics in modern psychiatry: a new breakthrough or the myth of a “magic bullet”?Neurology Bulletin · 2025-03-14Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.Molecular psychiatry · 2025-03-01Correction: Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-03-01A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.Psychedelic medicine (New Rochelle, N.Y.) · 2025-03-01EFFECT OF ACUTE PSILOCYBIN ON THERMAL AND NEUROPATHIC PAIN IN RODENTSThe international journal of neuropsychopharmacology · 2025-02-01Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.Expert review of neurotherapeutics · 2025-02-01Study finds encouraging results in psilocybin treatment for TRD patientsMental Health Weekly · 2025-01-10PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERSHealth and Society · 2025-01-08Therapieresistente Depression: Studie zur Psilocybin-augmentierten Psychotherapie nicht erfolgreichInFo Neurologie + Psychiatrie · 2025-01-01Psilocybin: From Psychiatric Pariah to Perceived Panacea.The American journal of psychiatry · 2025-01-01Clinical Pharmacokinetics of Psilocin After Psilocybin Administration: A Systematic Review and Post-Hoc AnalysisClinical Pharmacokinetics · 2025-01-01Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models.Frontiers in systems neuroscience · 2025-01-01Psilocybin Use in the Autism Spectrum Disorder: A Scoping Review.Clinical neuropharmacology · 2025-01-01Neuropsychological profiles of patients suffering from hallucinogen persisting perception disorder (HPPD): A comparative analysis with psychedelic-using and non-using controls.Scientific reports · 2024-12-31Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.Journal of eating disorders · 2024-12-27Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelicsFrontiers in Psychiatry · 2024-11-06Psilocybin-assisted psychotherapy improves psychiatric symptoms across multiple dimensions in patients with cancer.Nature. Mental health · 2024-11-01The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22The Afterglow Inventory (AGI) - validation of a new instrument for measuring subacute effects of classic serotonergic psychedelicsPsyArXiv · 2024-10-22Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms.British journal of pharmacology · 2024-10-01Naturalistic psychedelic therapy: The role of relaxation and subjective drug effects in antidepressant response.Journal of psychopharmacology (Oxford, England) · 2024-10-01The Effects of Psilocybin on Shared Experience in Film ProcessingClinicalTrials.gov · 2024-09-27Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.Pharmacological research · 2024-09-01Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report.Clinical case reports · 2024-09-01Rapidly Trading Down Depression's 3 Pillars to 5HT3-Receptors Through ECT or Psilocybin?Psychiatria Danubina · 2024-09-01A virtual clinical trial of psychedelics to treat patients with disorders of consciousnessbioRxiv · 2024-08-19Psychedelic use and psychological flexibility: The role of meaningful intention and decenteringJournal of Psychedelic Studies · 2024-08-16Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms.Psychopharmacology · 2024-08-01Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry methodJournal of Chromatography A · 2024-08-01Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experiencebioRxiv · 2024-06-13[Psilocybin-Assisted Treatment of Depression, Anxiety and Substance use Disorders: Neurobiological Basis and Clinical Application].Fortschritte der Neurologie-Psychiatrie · 2024-06-01Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety.JAMA psychiatry · 2024-06-01From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream MedicineEuropean Journal of Arts Humanities and Social Sciences · 2024-05-01Comparing Neural Correlates of Consciousness: From Psychedelics to Hypnosis and Meditation.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.Biological psychiatry. Cognitive neuroscience and neuroimaging · 2024-05-01The 'PSILAUT' protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin.BMC psychiatry · 2024-04-25Psychedelic therapists, pharma collaborate on clinical trialMental Health Weekly · 2024-04-13Psilocybin analog 4-OH-DiPT enhances fear extinction and GABAergic inhibition of principal neurons in the basolateral amygdala.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2024-04-01Use of Prescribed and Non-Prescribed Treatments for Cluster Headache in a Swedish Cohort.Brain sciences · 2024-03-31Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybin.Med (New York, N.Y.) · 2024-03-08American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey.Psychedelic medicine (New Rochelle, N.Y.) · 2024-03-01Indigenous psilocybin mushroom practices: An annotated bibliographyJournal of Psychedelic Studies · 2024-02-19Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.Psychology of addictive behaviors: journal of the Society of Psychologists in Addictive Behaviors · 2024-02-01The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits.Journal of applied toxicology: JAT · 2024-02-01Assessing the utility of in silico tools in early drug development: The case of a pharmaceutically relevant formulation of the prodrug psilocybinJournal of Drug Delivery Science and Technology · 2024-01-06RAPIDLY TRADING DOWN DEPRESSION'S3 PILLARS TO 5HT3-RECEPTORS THROUGH ECT OR PSILOCYBIN?University of Zagreb University Computing Centre (SRCE) · 2024-01-01Effects of psilocybin and sleep quality on brain water diffusivity and microstructure in healthy individuals and chronic cluster headache patientsNeuroscience Applied · 2024-01-01Associations between behavioral and neuronal changes in self-referential processing following a single, moderate dose of psilocybin in depressed patientsNeuroscience Applied · 2024-01-01Psilocybin-assisted psychotherapy as a potential treatment for eating disorders: a narrative review of preliminary evidence.Trends in psychiatry and psychotherapy · 2024-01-01Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study.European journal of pain (London, England) · 2024-01-01The revival of the psychedelic experience scale: Revealing its extended-mystical, visual, and distressing experiential spectrum with LSD and psilocybin studies.Journal of psychopharmacology (Oxford, England) · 2024-01-01CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity.Headache · 2024-01-01Safety pharmacology of acute psilocybin administration in healthy participants.Neuroscience applied · 2024-01-01CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.Journal of psychiatry & neuroscience: JPN · 2024-01-01Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use.Frontiers in psychiatry · 2024-01-01Peer support and psychedelics.Journal of military, veteran and family health · 2023-12-01Psilocybin-assisted psychotherapy for treatment-resistant depression: Which psychotherapy?International journal of mental health nursing · 2023-12-01[Feeling unwell after eating a piece of chocolate].Nederlands tijdschrift voor geneeskunde · 2023-11-23Aesthetic Chills Mitigate Maladaptive Cognition In DepressionResearch Square · 2023-11-14Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushroomsbioRxiv · 2023-10-23Psilocybin-induced changes in cerebral blood flow are associated with acute and baseline inter-individual differences.Scientific reports · 2023-10-14Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2023-10-01Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2023-10-01Single-Dose Psilocybin Treatment for Major Depressive Disorder: A Randomized Clinical Trial.JAMA · 2023-09-05Addressing the Current Knowledge and Gaps in Research Surrounding Lysergic Acid Diethylamide (LSD), Psilocybin, and Psilocin in Rodent ModelsCurrent Topics in Medicinal Chemistry · 2023-09-01Substance use, harm reduction attitudes and behaviors among attendees of nature rave parties in Israel.Harm reduction journal · 2023-08-09Psilocybin und Funktionalität bei DepressionInFo Neurologie + Psychiatrie · 2023-08-01Experiences of psilocybin treatment for clinical conditions: A qualitative meta-synthesis.International journal of mental health nursing · 2023-08-01FDA issues first draft guidance on psychedelic researchMental Health Weekly · 2023-06-30Psychedelics reopen the social reward learning critical periodNature · 2023-06-13Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult VolunteersClinicalTrials.gov · 2023-05-19The Need for Psychiatric Treatment among Polish Users of Psychoactive Substances Is Increasing: This and Other Results from the Newest PolDrugs Survey.Medicina (Kaunas, Lithuania) · 2023-05-09The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant DepressionClinicalTrials.gov · 2023-04-24118. Does Psilocybin Change Synaptic Vesicular Density in the Brains of Patients With Mild Cognitive Impairment?Biological Psychiatry · 2023-04-10Psilocybin to promote synaptogenesis in the brains of patients with mild cognitive impairmentMedical Hypotheses · 2023-04-05Pharmacokinetics and Pharmacodynamics of Oral Psilocybin Administration in Healthy Participants.Clinical pharmacology and therapeutics · 2023-04-01Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects ("MELO"): A Blinded, Placebo-Controlled, Dose-Finding StudyClinicalTrials.gov · 2023-03-20Is the Requirement for First-Person Experience of Psychedelic Drugs a Justified Component of a Psychedelic Therapist's Training?Cambridge quarterly of healthcare ethics: CQ: the international journal of healthcare ethics committees · 2023-03-02[Attitudes of Mental Health Experts Towards Psilocybin].Fortschritte der Neurologie-Psychiatrie · 2023-03-01Psychotherapists' openness to engage their patients in Psilocybin-Assisted Therapy for mental health treatment.Journal of affective disorders · 2023-02-15Wirkt Psilocybin nachhaltig antidepressiv?InFo Neurologie + Psychiatrie · 2023-02-01Single-dose psilocybin-assisted therapy in major depressive disorder: A placebo-controlled, double-blind, randomised clinical trial.EClinicalMedicine · 2023-02-01Corrigendum to 'Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial'.EClinicalMedicine · 2023-02-01Italian psychedelic therapies of the past century: An historical overviewDrug Science Policy and Law · 2023-01-01The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.Canadian journal of psychiatry. Revue canadienne de psychiatrie · 2023-01-01Psilocin - The “real deal” or an extraction byproductJournal of Forensic Sciences · 2023-01-01Functional MRI markers for treatment-resistant depression: Insights and challenges.Progress in brain research · 2023-01-01From prohibited to prescribed: The rescheduling of MDMA and psilocybin in AustraliaDrug Science Policy and Law · 2022-12-31Psilocybin containing mushrooms: a rapidly developing biotechnology industry in the psychiatry, biomedical and nutraceutical fields.3 Biotech · 2022-12-01Experts assess role of therapists in psychedelic-assisted therapyMental Health Weekly · 2022-11-05Kan psilocybin forbedre vores moral?Research at the University of Copenhagen (University of Copenhagen) · 2022-10-29Magic Mushrooms - an exploratory look at how mental health professionals feel and think about Psilocybin.Psychiatry research · 2022-10-01Psychedelics for Alzheimer's Disease Palliative Care.Advances in psychiatry and behavioral health · 2022-09-01From Mushrooms to Myolysis: A Case of Rhabdo in Psilocybin-Induced Mood and Psychotic Disorder.The Journal of nervous and mental disease · 2022-08-01Classic and non-classic psychedelics for substance use disorder: A review of their historic, past and current researchAddiction Neuroscience · 2022-06-22

Author directory

Robin Carhart-Harris176 publicationsDavid Nutt121 publicationsDavid Erritzøe84 publicationsFranz X. Vollenweider84 publicationsRoland R. Griffiths84 publicationsMatthew W. Johnson69 publicationsKatrin H. Preller64 publicationsFrederick S. Barrett60 publicationsGitte M. Knudsen57 publicationsLeor Roseman55 publicationsJames Rucker48 publicationsAlbert Garcia-Romeu46 publicationsTomáš Páleníček44 publicationsPatrick M. Fisher43 publicationsSandeep M. Nayak43 publicationsKim P. C. Kuypers42 publicationsDea Siggaard Stenbæk41 publicationsJoshua D. Rosenblat41 publicationsNatasha L. Mason39 publicationsPeter S. Hendricks37 publicationsAlan K. Davis35 publicationsChristopher Timmermann33 publicationsDavid Bryce Yaden33 publicationsMatthias E. Liechti33 publicationsMuhammad Ishrat Husain33 publicationsBrice Ozenne32 publicationsJohns Hopkins University31 publicationsGuy M. Goodwin30 publicationsHannes Kettner30 publicationsJohannes G. Ramaekers30 publicationsStephen Ross30 publicationsMichael P. Bogenschutz29 publicationsRoger S. McIntyre29 publicationsDirk Hoffmeister28 publicationsErich Seifritz27 publicationsRobert B. Kargbo27 publicationsRichard J. Zeifman26 publicationsBrian Anderson25 publicationsMartin Korsbak Madsen25 publicationsAllan H. Young24 publicationsCharles D. Nichols24 publicationsDrummond E-Wen McCulloch24 publicationsGabrielle Agin-Liebes24 publicationsJavier González-Maeso24 publicationsMartin Kuchař24 publicationsMorten L. Kringelbach24 publicationsNathan D. Sepeda24 publicationsNatalie Gukasyan23 publicationsPaul Liknaitzky23 publicationsXiaohui Wang23 publicationsFriederike Holze22 publicationsGustavo Deco22 publicationsScott Aaronson22 publicationsBrian S. Barnett21 publicationsBruna Giribaldi21 publicationsOlivia Carter21 publicationsOtto Simonsson21 publicationsRafael G. dos Santos21 publicationsAdam L. Halberstadt20 publicationsAlex Kwan20 publicationsManoj Doss20 publicationsMichael Kometer20 publicationsBenjamin Kelmendi19 publicationsBernard Lerer19 publicationsJacob S. Aday19 publicationsJaime E. C. Hallak19 publicationsJiřı́ Horáček19 publicationsMatthew B. Wall19 publicationsRoland A. Fischer19 publicationsRotem Petranker19 publicationsCharles L. Raison18 publicationsDavid E. Nichols18 publicationsEnzo Tagliazucchi18 publicationsMendel Kaelen18 publicationsRobert A. Schoevers18 publicationsAlexander M. Sherwood17 publicationsAmanda Feilding17 publicationsClaire J. Foldi17 publicationsDavid J. Hellerstein17 publicationsFelix Müller17 publicationsFernando Rosas17 publicationsFilip Tylš17 publicationsJeffrey Guss17 publicationsManish Agrawal17 publicationsMilan Scheidegger17 publicationsTomislav Majić17 publicationsWilliam A. Richards17 publicationsChristopher S. Stauffer16 publicationsKevin F. Boehnke16 publicationsMalievskaia E16 publicationsNadav Liam Modlin16 publicationsSophia Armand16 publicationsYale University16 publicationsCharles S. Grob15 publicationsEmmanuelle A. D. Schindler15 publicationsFelix Hasler15 publicationsGeyer MA15 publicationsJason B. Luoma15 publicationsKelly JR15 publicationsLea J. Mertens15 publicationsLindsey Marwood15 publicationsPablo Mallaroni15 publicationsSuresh Muthukumaraswamy15 publicationsTzuri Lifschytz15 publicationsUniversity Hospital15 publicationsAnna M. Becker14 publicationsBoadie W. Dunlop14 publicationsBrandon Weiss14 publicationsFederico Seragnoli14 publicationsGerhard Gründer14 publicationsHenrik Jungaberle14 publicationsJanis Fricke14 publicationsJeng-Yu Tsai14 publicationsJochen Gartz14 publicationsJoshua S. Siegel14 publicationsMeg J Spriggs14 publicationsMika Turkia14 publicationsNathalie M. Rieser14 publicationsRodrigo B. Mansur14 publicationsSusan L. Rossell14 publications